Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc. is a biopharmaceutical company specializing in the research, development, and commercialization of treatments targeting neurological and endocrine disorders. The company is dedicated to addressing unmet medical needs in neuroscience, focusing on conditions such as movement disorders, psychiatric illnesses, and other neurological diseases. Neurocrine Biosciences is actively engaged in both discovery and advanced clinical development, with recent initiatives including late-stage clinical trials for schizophrenia therapies. Its portfolio encompasses products and candidates designed to impact the pharmaceuticals sector, particularly for patients with complex and chronic health challenges. By advancing innovative therapies, Neurocrine Biosciences holds a significant presence in the life sciences market, contributing to the progress of neuroscience-driven healthcare solutions and reinforcing its role as a key player in the global biopharmaceutical industry.